Vision and Proprioception Evaluation With Robotics After Stroke (VIPERS)

November 19, 2025 updated by: Dr. Sean Dukelow

Stroke is highly prevalent in Canada and can lead to profound upper limb impairments in motor and sensory function, as well and vision. Clinical assessments for these functions often lack sensitivity making detecting impairments and tracking their recovery after stroke difficult. It is known that sensory function and vision interact to inform motor behaviours, yet how each of these modalities might contribute to motor impairments and subsequent recovery after stroke is undetermined.

Using robotics to assess neurologic function after a stroke can be very beneficial, as they can measure on the scale of millimetres and milliseconds which can more easily detect subtle deficits in a persons function. Compared to current clinical tools, robotics offer greater objectivity and reliability, as they do not rely on the examiners clinical experience and/or impression. The use of robotics not only offers a more precise measurement, but robotics assessments can be completed in a relatively short amount of time, in comparison to some of the current clinical assessment tools, which can take along time to complete. In addition to robotics, collecting neuroimaging (MRI/CT) will allow us to relate our robotic and eye-tracking measures to neuroanatomical information about the person's stroke. With this data, we will assess how the brain changes post-stroke in relation to the recovery of motor, sensory and visual functions.

This research will: 1) examine the relationship between visual and proprioceptive impairment on motor and eye movement behaviour over time after stroke, and 2) identify neuroanatomical correlates of visual, proprioceptive and sensory integrative dysfunction that impact motor recovery after stroke and examine the ability of regional damage and network disruption to predict recovery.

Objectives:

  1. Determine the impact of visual field loss and visual neglect in stroke survivors with impaired movement over the first 6 months post-stroke.
  2. Identify the impact of Proprioceptive Impairment and Sensory Integration Impairment on recovery post-stroke using robotics and eye tracking.
  3. Understand the impact of damage to neuroanatomic structures involved in vision, proprioception and sensory integration on motor recovery using MRI after stroke.

The VIPERS study is recruiting both stroke and control participants. Stroke participants are recruited within the first 28 days post-stroke and are assessed longitudinally across the first 6-months post-stroke (four study timepoints). Control participants just complete a single session.

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Estimated)

425

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alberta
      • Calgary, Alberta, Canada
        • Foothills Medical Centre
        • Contact:
      • Calgary, Alberta, Canada
        • Carewest Dr. Vernon Fanning Centre
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

425 participants will be recruited for this study (225 stroke participants and 200 matched control participants who have not experienced a stroke). All participant will be aged 18 or older.

Description

Inclusion criteria for stroke participants:

  • 18 years of age or older
  • First clinical diagnosis of stroke
  • No recent muscle skeletal injuries to the arms, neck, or back
  • No history of other neurological disease/injury (Ie. MS, Parkinson's, Brain Tumour, etc.)
  • Corrected vision 20/50 or better
  • Able to follow multi-step commands.
  • Living independently prior to stroke
  • Can consent to participate in research

Inclusion criteria for control participants:

  • 18 years of age or older
  • No history stroke, or Trans Ischemic Attack (TIA)
  • No recent muscle skeletal injures to the arms, neck, or back
  • No history of other neurological disease/ injury (Ie. MS, Parkinson's, Brain Tumour, etc)
  • No pre-stroke history of eye movement disorders
  • Corrected vision 20/50 or better
  • Able to follow multi-step commands
  • Can consent to participate in research

Exclusion Criteria:

  • Prior history of stroke/significant neurologic problem (e.g. Parkinson's)
  • Symptomatic medical conditions that would interfere with participation (e.g. uncontrolled angina)
  • Contraindications to Magnetic Resonance Imaging (MRI)
  • Pre-stroke history of visual field/oculomotor abnormalities.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Stroke
Stroke Participants - Individuals with first time stroke
Control
Control Participants - Individuals not suffering stroke or other neurological disorders

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Visually Guided Reaching Score
Time Frame: Enrolment to six-months post stroke
Enrolment to six-months post stroke

Other Outcome Measures

Outcome Measure
Time Frame
Visually Guided Reaching Score (no vision)
Time Frame: Enrolment to six-months post stroke
Enrolment to six-months post stroke
Proprioceptive Saccade task scores
Time Frame: Enrolment to six-months post stroke
Enrolment to six-months post stroke
Arm Movement Matching (vision)
Time Frame: Enrolment to six-months post stroke
Enrolment to six-months post stroke
Arm Movement Matching
Time Frame: Enrolment to six-months post stroke
Enrolment to six-months post stroke
Arm position matching (vision)
Time Frame: Enrolment to six-months post stroke
Enrolment to six-months post stroke
Arm Position Matching Score
Time Frame: Enrolment to six-months post stroke
Enrolment to six-months post stroke
Visually Guided Reaching Score
Time Frame: From enrolment to six-months post stroke
From enrolment to six-months post stroke
Anti-saccade task score
Time Frame: Enrolment to six-months post stroke
Enrolment to six-months post stroke
Pro-saccade task score
Time Frame: Enrolment to six-months post-stroke
Enrolment to six-months post-stroke
Behavioural Inattention Test (BIT)
Time Frame: Enrolment to six-months post-stroke
Enrolment to six-months post-stroke
Visual Impairment Screening Assessment (VISA)
Time Frame: Enrolment to six-months post-stroke
Enrolment to six-months post-stroke
Humphrey's Visual Field Analyzer (VFA)
Time Frame: Enrolment to six-months post stroke
Enrolment to six-months post stroke
Thumb Localization Test (TLT)
Time Frame: Enrolment to six-months post stroke
Enrolment to six-months post stroke
Medical Research Council Strength Scale
Time Frame: Enrolment to six-months post stroke
Enrolment to six-months post stroke
Modified Ashworth Scale (MAS)
Time Frame: Enrolment to six-months post stroke
Enrolment to six-months post stroke
Fugl-Meyer Assessment-Upper Extremity (FMA-UE)
Time Frame: Enrolment to six-months post stroke
Enrolment to six-months post stroke
Functional Independence Measure (FIM)
Time Frame: Enrolment to six-months post stroke
Enrolment to six-months post stroke

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2026

Primary Completion (Estimated)

January 1, 2031

Study Completion (Estimated)

June 1, 2031

Study Registration Dates

First Submitted

November 19, 2025

First Submitted That Met QC Criteria

November 19, 2025

First Posted (Actual)

November 28, 2025

Study Record Updates

Last Update Posted (Actual)

November 28, 2025

Last Update Submitted That Met QC Criteria

November 19, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • REB25-1170
  • 197953 (Other Grant/Funding Number: Canadian Institutes of Health Research)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Formal data transfer agreements/legal contracts are required to share IPD with other researchers outside of the main study site.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Subscribe